Evidence map›Paper›PMID 31355416›Full record

ArticleHistology and histopathology2020

Long noncoding RNA small nucleolar RNA host gene 12 promotes papillary thyroid carcinoma cell growth and invasion by targeting miR-16-5p.

Xiaocheng Feng, Xuehong Dong, Dingting Wu, Hanxin Zhao, Changqin Xu, Hong Li

Abstract read
PubMed Publisher
In one paragraph

Article in Histology and histopathology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.2field-weighted citation impact, top 24% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 16 citations in OpenAlex.

  1. Review
  2. SnoRNAs: The promising targets for anti-tumor therapy.Journal of pharmaceutical analysis · 2024
    Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Observational
  9. Long noncoding RNAAging · 2020
    Article
  10. Review
  11. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 1 institution in 1 country.

Xiaocheng FengDepartment of Endocrinology and Metabolism, Zhejiang University Affiliated Sir Run Shaw Hospital, School of Medicine, Hangzhou, P.R. China. fengxc@zju.edu.cn.
Xuehong DongDepartment of Endocrinology and Metabolism, Zhejiang University Affiliated Sir Run Shaw Hospital, School of Medicine, Hangzhou, P.R. China.
Dingting WuDepartment of Nutrition Division, Zhejiang University Affiliated Fourth Hospital, School of Medicine, Yiwu, P.R. China.
Hanxin ZhaoDepartment of Endocrinology and Metabolism, Zhejiang University Affiliated Sir Run Shaw Hospital, School of Medicine, Hangzhou, P.R. China.
Changqin XuDepartment of Pneumology, Hangzhou Normal University Affiliated Hospital, Hangzhou, P.R. China.
Hong LiDepartment of Endocrinology and Metabolism, Zhejiang University Affiliated Sir Run Shaw Hospital, School of Medicine, Hangzhou, P.R. China.
Anhui Medical University · CN

Funding

Medical and Health Scientific Research Project of Zhejiang Province 2013KYA113Medical and Health Scientific Research Project of Zhejiang Province 201466009National Natural Science Foundation of China for young scientists 30900703Science and Technology Development Project of Hangzhou City 20160533B19Zhejiang Natural Science Foundation LY15H070002Zhejiang Natural Science Foundation LY15H070010
6 · The paper itself

Abstract

Emerging evidence has shown that long noncoding RNA (lncRNA) plays an important role in various types of malignant cancer. Small nucleolar RNA host gene 12 (SNHG12) was found to be upregulated and to act as an oncogene in several cancers. However, the function and regulatory mechanism of SNHG12 remain unclear in papillary thyroid carcinoma (PTC). In this study, SNHG12 was found to be increased in PTC tissues and cell lines using quantitative real-time PCR. Knockdown of SNHG12 significantly inhibited PTC cell proliferation, migration and invasion and induced apoptosis in vitro. Mechanistic investigations revealed that SNHG12 functions as a competing endogenous RNA (ceRNA) to sponge miR-16-5p, which was downregulated in PTC tissues. In addition, rescue assays further confirmed that SNHG12 contributed to the progression of PTC through regulating miR-16-5p expression. These results indicated that SNHG12 might contribute to tumor progression in PTC by acting as a ceRNA to sponge miR-16-5p.

Indexed as

Cell ProliferationGene Expression Regulation, NeoplasticHumansMicroRNAsNeoplasm InvasivenessRNA, Long NoncodingThyroid Cancer, PapillaryThyroid NeoplasmsMicroRNAsMIRN16 microRNA, humanRNA, Long NoncodingSNHG12 long non-coding RNA, human

Identifiers

PMID31355416
OpenAlexW2996192099

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.